An investigation into the effect of the type IV phosphodiesterase inhibitor rolipram in the modulation of glutamate release from rat prefrontocortical nerve terminals

Synapse ◽  
2005 ◽  
Vol 59 (1) ◽  
pp. 41-50 ◽  
Author(s):  
Su-Jane Wang
Keyword(s):  
Glutamate Release ◽  
Phosphodiesterase Inhibitor ◽  
Nerve Terminals ◽  
Type Iv ◽  
Type Iv Phosphodiesterase

Cicaprost and the type IV phosphodiesterase inhibitor, rolipram, synergize in suppression of tumor necrosis factor-α synthesis

1996 ◽  
Vol 299 (1-3) ◽  
pp. 229-233 ◽  
Author(s):  
Tim F. Greten ◽  
Bhanu Sinha ◽  
Christiane Haslberger ◽  
Andreas Eigler ◽  
Stefan Endres
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Tumor Necrosis Factor Α ◽  
Phosphodiesterase Inhibitor ◽  
Type Iv ◽  
Factor Α ◽  
Necrosis Factor ◽  
Type Iv Phosphodiesterase

Rolipram, a specific type IV phosphodiesterase inhibitor, ameliorates indomethacin-induced gastric mucosal injury in rats

2003 ◽  
Vol 9 (3) ◽  
pp. 195-200 ◽  
Author(s):  
Chieko Nakamura ◽  
Michiro Otaka ◽  
Masaru Odashima ◽  
Mario Jin ◽  
Noriaki Konishi ◽  
...  
Keyword(s):  
Phosphodiesterase Inhibitor ◽  
Mucosal Injury ◽  
Gastric Mucosal Injury ◽  
Type Iv ◽  
Type Iv Phosphodiesterase

scholarly journals Prevention of EAE in non-human primates by a type IV phosphodiesterase inhibitor that suppresses tumor necrosis factor

1994 ◽  
Vol 54 (1-2) ◽  
pp. 163 ◽  
Author(s):  
C.P. Genain ◽  
M.H. Nguyen ◽  
D. Faulds ◽  
A. Uccelli ◽  
R.L. Davis ◽  
...  
Keyword(s):  
Tumor Necrosis Factor ◽  
Tumor Necrosis ◽  
Phosphodiesterase Inhibitor ◽  
Type Iv ◽  
Necrosis Factor ◽  
Type Iv Phosphodiesterase

The Toxicity of Repeated Exposures to Rolipram, a Type IV Phosphodiesterase Inhibitor, in Rats

1996 ◽  
Vol 78 (1) ◽  
pp. 44-49 ◽  
Author(s):  
Jeffrey L. Larson ◽  
Michael V Pino ◽  
Lee E. Geiger ◽  
Christopher R. Simeone
Keyword(s):  
Phosphodiesterase Inhibitor ◽  
Type Iv ◽  
Type Iv Phosphodiesterase

Type IV Phosphodiesterase Inhibitor Suppresses Insulin-Dependent Myocardial Glucose Uptake

2001 ◽  
Vol 28 (4) ◽  
pp. 290-291 ◽  
Author(s):  
Kenichi Imahashi ◽  
Jun Yoshioka ◽  
Tsuyoshi Yamakita ◽  
Suzuyo Yamano ◽  
Hideo Kusuoka ◽  
...  
Keyword(s):  
Glucose Uptake ◽  
Phosphodiesterase Inhibitor ◽  
Myocardial Glucose Uptake ◽  
Type Iv ◽  
Insulin Dependent ◽  
Type Iv Phosphodiesterase

scholarly journals Neutrophil A2AAdenosine Receptor Inhibits Inflammation in a Rat Model of Meningitis: Synergy with the Type IV Phosphodiesterase Inhibitor, Rolipram

1999 ◽  
Vol 180 (5) ◽  
pp. 1550-1560 ◽  
Author(s):  
Gail W. Sullivan ◽  
Joel Linden ◽  
Bradley L. Buster ◽  
W. Michael Scheld
Keyword(s):  
Rat Model ◽  
Phosphodiesterase Inhibitor ◽  
Type Iv ◽  
Type Iv Phosphodiesterase

The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-α and nitric oxide

1995 ◽  
Vol 17 (7) ◽  
pp. 605-610 ◽  
Author(s):  
Tim F. Greten ◽  
Andreas Eigler ◽  
Bhanu Sinha ◽  
Jochen Moeller ◽  
Stefan Endres
Keyword(s):  
Nitric Oxide ◽  
Phosphodiesterase Inhibitor ◽  
Proinflammatory Mediators ◽  
Type Iv ◽  
Tnf Α ◽  
Type Iv Phosphodiesterase

scholarly journals Amelioration of collagen II-induced arthritis in rats by the type IV phosphodiesterase inhibitor Rolipram

1997 ◽  
Vol 108 (3) ◽  
pp. 415-419 ◽  
Author(s):  
U. NYMAN ◽  
Å. ÜSSENER ◽  
E. LARSSON ◽  
J. LORENTZEN ◽  
L. KLARESKOG
Keyword(s):  
Phosphodiesterase Inhibitor ◽  
Type Iv ◽  
Collagen Ii ◽  
Type Iv Phosphodiesterase

Mitigation of Stress-Induced Gastric Mucosal Lesions by a Specific Type IV Phosphodiesterase Inhibitor

2007 ◽  
Vol 52 (3) ◽  
pp. 711-716
Author(s):  
Sayuri Kato ◽  
Michiro Otaka ◽  
Masaru Odashima ◽  
Toshihiro Sato ◽  
Mario Jin ◽  
...  
Keyword(s):  
Phosphodiesterase Inhibitor ◽  
Gastric Mucosal Lesions ◽  
Type Iv ◽  
Mucosal Lesions ◽  
Type Iv Phosphodiesterase
Sign in / Sign up

Export Citation Format

Share Document